Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Avan

Showing results (241-250 of 462) with videos related to

Pageof 47
Sort By:
Current Pharmaceutical Design|June 2, 2025
Metabolic Targets in CRC: The Emerging Role of Cytochrome P450 InhibitorsHawraa Ibrahim Alshakarchi, Hanieh Azari, Zuhair Mohammed Ali Jeddoa, et al.
Current Pharmaceutical Design|March 9, 2023
Circulating Tumor Cells and Cell-free Nucleic Acids as Biomarkers in Colorectal CancerGhazaleh Pourali, Ghazaleh Khalili-Tanha, Elham Nazari, et al.
Avicenna Journal of Phytomedicine|August 1, 2024
Therapeutic potency of curcumin on radiodermatitis: A systematic reviewHossein Abdeahad, Nikoo Saeedi, Afsane Bahrami, et al.
Current Drug Targets|December 6, 2023
Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic CancerGhazaleh Pourali, Nima Zafari, Mahla Velayati, et al.
Molecular Cancer Therapeutics|May 25, 2012
Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cellsAmir Avan, Francesco Crea, Elisa Paolicchi, et al.
Journal of Cellular Physiology|November 19, 2017
The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancerAmir Tajbakhsh, Alireza Pasdar, Mehdi Rezaee, et al.
Current Pharmaceutical Design|September 26, 2022
Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic ApproachNima Zafari, Mahla Velayati, Sedigheh Damavandi, et al.
Current Pharmaceutical Design|September 15, 2012
Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancerAmir Avan, Karl Quint, Francesco Nicolini, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2024
Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinomaSofia M Sousa, Helena Branco, Amir Avan, et al.
Current Medicinal Chemistry|June 11, 2024
Biosensors for Detection of Hepatitis B Virus: ReviewAmir Hossein Esfandiari, Hadis Hajipir Farkhani, Zahra Hashemi Javan, et al.
Pageof 47

Showing results (241-250 of 462) with videos related to

Sort By:
Pageof 47
Current Pharmaceutical Design|June 2, 2025
Metabolic Targets in CRC: The Emerging Role of Cytochrome P450 InhibitorsHawraa Ibrahim Alshakarchi, Hanieh Azari, Zuhair Mohammed Ali Jeddoa, et al.
Current Pharmaceutical Design|March 9, 2023
Circulating Tumor Cells and Cell-free Nucleic Acids as Biomarkers in Colorectal CancerGhazaleh Pourali, Ghazaleh Khalili-Tanha, Elham Nazari, et al.
Avicenna Journal of Phytomedicine|August 1, 2024
Therapeutic potency of curcumin on radiodermatitis: A systematic reviewHossein Abdeahad, Nikoo Saeedi, Afsane Bahrami, et al.
Current Drug Targets|December 6, 2023
Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic CancerGhazaleh Pourali, Nima Zafari, Mahla Velayati, et al.
Molecular Cancer Therapeutics|May 25, 2012
Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cellsAmir Avan, Francesco Crea, Elisa Paolicchi, et al.
Journal of Cellular Physiology|November 19, 2017
The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancerAmir Tajbakhsh, Alireza Pasdar, Mehdi Rezaee, et al.
Current Pharmaceutical Design|September 26, 2022
Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic ApproachNima Zafari, Mahla Velayati, Sedigheh Damavandi, et al.
Current Pharmaceutical Design|September 15, 2012
Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancerAmir Avan, Karl Quint, Francesco Nicolini, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2024
Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinomaSofia M Sousa, Helena Branco, Amir Avan, et al.
Current Medicinal Chemistry|June 11, 2024
Biosensors for Detection of Hepatitis B Virus: ReviewAmir Hossein Esfandiari, Hadis Hajipir Farkhani, Zahra Hashemi Javan, et al.
Pageof 47